Blackhill Capital’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $663K | Hold |
3,400
| – | – | 0.03% | 33 |
|
|
2026
Q1 | $763K | Hold |
3,400
| – | – | 0.04% | 31 |
|
|
2025
Q4 | $819K | Hold |
3,400
| – | – | 0.04% | 29 |
|
|
2025
Q3 | $931K | Hold |
3,400
| – | – | 0.05% | 29 |
|
|
2025
Q2 | $877K | Hold |
3,400
| – | – | 0.05% | 28 |
|
|
2025
Q1 | $761K | Hold |
3,400
| – | – | 0.04% | 32 |
|
|
2024
Q4 | $778K | Hold |
3,400
| – | – | 0.04% | 30 |
|
|
2024
Q3 | $830K | Hold |
3,400
| – | – | 0.05% | 34 |
|
|
2024
Q2 | $651K | Hold |
3,400
| – | – | 0.04% | 34 |
|
|
2024
Q1 | $673K | Hold |
3,400
| – | – | 0.04% | 34 |
|
|
2023
Q4 | $585K | Hold |
3,400
| – | – | 0.05% | 33 |
|
|
2023
Q3 | $503K | Sell |
3,400
-3,400
| -50% | -$615K | 0.05% | 32 |
|
|
2023
Q2 | $1.49M | Hold |
6,800
| – | – | 0.16% | 26 |
|
|
2023
Q1 | $1.49M | Hold |
6,800
| – | – | 0.17% | 28 |
|
|
2022
Q4 | $1.42M | Hold |
6,800
| – | – | 0.16% | 27 |
|
|
2022
Q3 | $1.48M | Sell |
6,800
-400
| -6% | -$91K | 0.18% | 29 |
|
|
2022
Q2 | $1.51M | Hold |
7,200
| – | – | 0.17% | 30 |
|
|
2022
Q1 | $1.75M | Hold |
7,200
| – | – | 0.17% | 30 |
|
|
2021
Q4 | $1.88M | Hold |
7,200
| – | – | 0.16% | 29 |
|
|
2021
Q3 | $1.9M | Hold |
7,200
| – | – | 0.16% | 29 |
|
|
2021
Q2 | $1.77M | Hold |
7,200
| – | – | 0.16% | 29 |
|
|
2021
Q1 | $1.4M | Hold |
7,200
| – | – | 0.12% | 29 |
|
|
2020
Q4 | $1.53M | Hold |
7,200
| – | – | 0.18% | 29 |
|
|
2020
Q3 | $1.23M | Buy |
7,200
+1,000
| +16% | +$185K | 0.17% | 29 |
|
|
2020
Q2 | $1.19M | Hold |
6,200
| – | – | 0.18% | 31 |
|
|
2020
Q1 | $913K | Hold |
6,200
| – | – | 0.19% | 33 |
|
|
2019
Q4 | $961K | Hold |
6,200
| – | – | 0.14% | 37 |
|
|
2019
Q3 | $838K | Buy |
6,200
+700
| +13% | +$91.7K | 0.13% | 41 |
|
|
2019
Q2 | $671K | Hold |
5,500
| – | – | 0.11% | 43 |
|
|
2019
Q1 | $572K | Hold |
5,500
| – | – | 0.1% | 44 |
|
|
2018
Q4 | $626K | Sell |
5,500
-500
| -8% | -$53.6K | 0.12% | 39 |
|
|
2018
Q3 | $692K | Buy |
+6,000
| New | +$657K | 0.11% | 42 |
|
Other funds holding RMD
Blackhill Capital's RMD Position: Q2 2026 in Review
Blackhill Capital held its ResMed (RMD) position steady in Q2 2026 at 3,400 shares worth $663K. The position accounts for 0.03% of the portfolio, ranked #33.
Blackhill Capital first reported a position in RMD in Q3 2018 and has held it in 32 quarters since. The position peaked at $1.9M in Q3 2021. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Blackhill Capital held 3,400 shares of ResMed worth $663K as of Q2 2026.
- Blackhill Capital left its ResMed share count unchanged in Q2 2026.
- ResMed made up 0.03% of Blackhill Capital's portfolio in Q2 2026, its #33 holding.
- Blackhill Capital first reported a position in ResMed in Q3 2018 and has held it in 32 quarters since.
- Blackhill Capital's ResMed position peaked at $1.9M in Q3 2021.
- 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Blackhill Capital's 13F filing for Q2 2026, filed 13 Aug 2026.